Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Brady

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Biological Chemistry|October 10, 2001
Tip60 is a co-activator specific for class I nuclear hormone receptorsL Gaughan, M E Brady, S Cook, et al.
International Journal of Clinical Pharmacology and Biopharmacy|January 1, 1979
Animal model and pharmacokinetic interpretation of nicotine poisoning in manM E Brady, W A Ritschel, D A Saelinger, et al.
European Journal of Clinical Pharmacology|January 1, 1987
The pharmacokinetics of single high doses of dexamethasone in cancer patientsM E Brady, G P Sartiano, S L Rosenblum, et al.
Molecular Endocrinology (Baltimore, Md.)|October 24, 2000
Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filaminD M Ozanne, M E Brady, S Cook, et al.
The Journal of Biological Chemistry|June 11, 1999
Tip60 is a nuclear hormone receptor coactivatorM E Brady, D M Ozanne, L Gaughan, et al.
European Journal of Clinical Pharmacology|December 28, 1977
Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in manW A Ritschel, M E Brady, H S Tan, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The disposition and protein binding of batanopride and its metabolites in subjects with renal impairmentJ V St Peter, M E Brady, E F Foote, et al.
BMC Nephrology|September 24, 2020
Symptom-burden in people living with frailty and chronic kidney diseaseA C Nixon, T J Wilkinson, H M L Young, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Biological Chemistry|October 10, 2001
Tip60 is a co-activator specific for class I nuclear hormone receptorsL Gaughan, M E Brady, S Cook, et al.
International Journal of Clinical Pharmacology and Biopharmacy|January 1, 1979
Animal model and pharmacokinetic interpretation of nicotine poisoning in manM E Brady, W A Ritschel, D A Saelinger, et al.
European Journal of Clinical Pharmacology|January 1, 1987
The pharmacokinetics of single high doses of dexamethasone in cancer patientsM E Brady, G P Sartiano, S L Rosenblum, et al.
Molecular Endocrinology (Baltimore, Md.)|October 24, 2000
Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filaminD M Ozanne, M E Brady, S Cook, et al.
The Journal of Biological Chemistry|June 11, 1999
Tip60 is a nuclear hormone receptor coactivatorM E Brady, D M Ozanne, L Gaughan, et al.
European Journal of Clinical Pharmacology|December 28, 1977
Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in manW A Ritschel, M E Brady, H S Tan, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The disposition and protein binding of batanopride and its metabolites in subjects with renal impairmentJ V St Peter, M E Brady, E F Foote, et al.
BMC Nephrology|September 24, 2020
Symptom-burden in people living with frailty and chronic kidney diseaseA C Nixon, T J Wilkinson, H M L Young, et al.
Pageof 2